Back to Search
Start Over
COVID ‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration
- Source :
- Dermatologic Therapy
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- SARS‐CoV‐2 become pandemics and there is still a dearth of data about its the potentially among dermatological patients under biologics. We aimed to assess health literacy, disease knowledge, treatment dissatisfaction and biologics attitudes toward COVID‐19. We performed a cross‐sectional, questionnaire‐based survey on 98/105 consecutive dermatological patients treated with biologics—51 suffering from plaque psoriasis, 22 from atopic dermatitis, and 25 from hidradenitis suppurativa. An ad hoc, validated questionnaire has 44 items investigating the following domains: knowledge of COVID‐19 related to (a) epidemiology, (b) pathogenesis, (c) clinical symptoms, (d) preventive measures, and (e) attitudes. Patients data and questionnaires were collected. Despite only 8.1% thought that biologics may increase the risk of COVID‐19, 18.4% and 21.4% of the patients were evaluating the possibility to discontinue or modify the dosage of the current biologic therapy, respectively. Globally, male patients (P = .001) with higher scholarity level (P = .005) displayed higher knowledge of COVID‐19. Patients with lower DLQI (P = .006), longer disease duration (P = .051) and lower scholarity (P = .007) have thought to discontinue/modify autonomously their biologic therapy. At the multivariate logistic regression, only the knowledge of epidemiology and preventive measures resulted independent predictors of continuation vs discontinuation and modification vs no modification, respectively. Dermatologists should promote COVID‐19 knowledge to prevent biologics disruption.
- Subjects :
- Adult
Male
Health Knowledge, Attitudes, Practice
medicine.medical_specialty
Pneumonia, Viral
Health literacy
Comorbidity
Disease
Dermatology
Logistic regression
Skin Diseases
SARS‐CoV‐2
Short Papers
Betacoronavirus
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
COVID‐19
Surveys and Questionnaires
Internal medicine
Psoriasis
Epidemiology
medicine
Humans
Short Paper
biologics
Hidradenitis suppurativa
Pandemics
Retrospective Studies
Biological Products
atopic dermatitis
SARS-CoV-2
COVID‐19 questionnaire
business.industry
hidradenitis suppurativa
COVID-19
psoriasis
Atopic dermatitis
General Medicine
Prognosis
medicine.disease
Discontinuation
Cross-Sectional Studies
Italy
030220 oncology & carcinogenesis
Female
Coronavirus Infections
business
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 15298019 and 13960296
- Database :
- OpenAIRE
- Journal :
- Dermatologic Therapy
- Accession number :
- edsair.doi.dedup.....ea743e7eaa1b053cb94684ca8103f3bf
- Full Text :
- https://doi.org/10.1111/dth.13508